--- title: "Sparta 10-Q: Q3 Revenue $92.16M, EPS (Loss) $(0.01) — Significant YTD and net losses" type: "News" locale: "en" url: "https://longbridge.com/en/news/280217300.md" description: "Sparta reported Q3 revenue of $92.16 million, a 17% year-over-year increase, primarily from merchant financing fees. The company incurred a net loss of $(405.29) million for the quarter and $(1,399.21) million year-to-date, with operating expenses rising 15%. Gross profit was $86.67 million. The company is expanding digital offerings and launched SpartaPayIQ. A joint venture aims to support Brazilian importers. Staffing is minimal, with plans for a Sparta Crypto platform launch in 2026, pending execution." datetime: "2026-03-23T21:21:01.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/280217300.md) - [en](https://longbridge.com/en/news/280217300.md) - [zh-HK](https://longbridge.com/zh-HK/news/280217300.md) generator: "portal-rs" --- # Sparta 10-Q: Q3 Revenue $92.16M, EPS (Loss) $(0.01) — Significant YTD and net losses Sparta reported third-quarter total revenue of $92.16 million, driven primarily by merchant financing fees, while reporting a net loss per share of $(0.01) for the three-month period. The company posted a three-month net loss of $(405.29) million and a nine-month net loss of $(1,399.21) million, with operating expenses rising year-over-year. Gross profit for the quarter was reported at $86.67 million after cost of goods sold of $5,490. **Financial Highlights** - **Total Revenue (Three months)**: $92,162,000 — a 17% year-over-year increase driven primarily by merchant financing fees. - **Gross profit (Three months)**: $86,672,000 (after $5,490 cost of goods sold). - **Loss from operations**: $(208,217,000); operating expenses increased 15% year-over-year. - **Net loss (Net Income)**: $(405,288,000) for the three months; $(1,399,213,000) for the nine months. - **Loss from continuing operations attributable to common stockholders (Net Income Per Share)**: $(0.01) per share (three months); $(0.03) per share (nine months). **Business Highlights** - **Revenue Growth**: Year-to-date revenue rose 71% to $288,000, attributed primarily to increased merchant financing fees. - **Channel Shift**: Expanded digital offerings are core channels, including mobile applications, vehicle history reports, and e-commerce wellness sales. - **Brand and Product Initiatives**: Launched and marketed SpartaPayIQ payment gateway and NewWorldHealthBrands; continued global distribution of Vehicle History Reports. - **Joint Venture and Market Targeting**: Agoge fintech joint venture aims to serve Brazilian importers with a staged financing platform and is seeking debt financing to scale operations. - **Staffing & Product Roadmap**: Operates with a small core team (4 full-time, 3 part-time) and plans a platform launch for Sparta Crypto targeted for 2026, contingent on execution. Original SEC Filing: SPARTA COMMERCIAL SERVICES, INC. \[ SRCO \] - 10-Q - Mar. 23, 2026 **Disclaimer** This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC. ### Related Stocks - [SUPL.US](https://longbridge.com/en/quote/SUPL.US.md) - [SPTN.US](https://longbridge.com/en/quote/SPTN.US.md) ## Related News & Research - [Americold’s Expanded PLUS Cold Chain Deal Might Change The Case For Investing In Americold (COLD)](https://longbridge.com/en/news/286806341.md) - [C.H. Robinson Shareholders Approve Proposals at 2026 Meeting](https://longbridge.com/en/news/285997625.md) - [United Parcel Service, Inc. $UPS Shares Purchased by Northwestern Mutual Wealth Management Co.](https://longbridge.com/en/news/287333413.md) - [Prologis Partners For $1.2 Billion Logistics Platform In Europe](https://longbridge.com/en/news/282230617.md) - [C.H. Robinson Worldwide, Inc. $CHRW Stake Raised by Principal Financial Group Inc.](https://longbridge.com/en/news/285806797.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**